KEGG   PATHWAY: elk05340
Entry
elk05340                    Pathway                                
Name
Primary immunodeficiency - Enhydra lutris kenyoni (northern sea otter)
Description
Primary immunodeficiencies (PIs) are a heterogeneous group of disorders, which affect cellular and humoral immunity or non-specific host defense mechanisms mediated by complement proteins, and cells such as phagocytes and natural killer (NK) cells. These disorders of the immune system cause increased susceptibility to infection, autoimmune disease, and malignancy. Most of PIs are due to genetic defects that affect cell maturation or function at different levels during hematopoiesis. Disruption of the cellular immunity is observed in patients with defects in T cells or both T and B cells. These cellular immunodeficiencies comprise 20% of all PIs. Disorders of humoral immunity affect B-cell differentiation and antibody production. They account for 70% of all PIs.
Class
Human Diseases; Immune disease
Pathway map
elk05340  Primary immunodeficiency
elk05340

Organism
Enhydra lutris kenyoni (northern sea otter) [GN:elk]
Gene
111141392  adenosine deaminase [KO:K01488] [EC:3.5.4.4]
111141253  interleukin-7 receptor subunit alpha isoform X1 [KO:K05072]
111161041  cytokine receptor common subunit gamma [KO:K05070]
111143876  tyrosine-protein kinase JAK3 isoform X1 [KO:K11218] [EC:2.7.10.2]
111155594  protein artemis isoform X1 [KO:K10887] [EC:3.1.-.-]
111150268  V(D)J recombination-activating protein 1 [KO:K10628] [EC:2.3.2.27]
111150029  V(D)J recombination-activating protein 2 [KO:K10988]
111153823  T-cell surface glycoprotein CD3 delta chain isoform X1 [KO:K06450]
111153962  T-cell surface glycoprotein CD3 epsilon chain isoform X1 [KO:K06451]
111150935  receptor-type tyrosine-protein phosphatase C isoform X1 [KO:K06478] [EC:3.1.3.48]
111159821  T-cell surface glycoprotein CD4 isoform X1 [KO:K06454]
111148035  T-cell surface glycoprotein CD8 alpha chain [KO:K06458]
111148090  T-cell surface glycoprotein CD8 beta chain [KO:K06459]
111155678  autoimmune regulator [KO:K10603]
111152176  antigen peptide transporter 1 [KO:K05653] [EC:7.4.2.14]
111152449  antigen peptide transporter 2 [KO:K05654] [EC:7.4.2.14]
111142990  tyrosine-protein kinase Lck [KO:K05856] [EC:2.7.10.2]
111155922  tyrosine-protein kinase ZAP-70 [KO:K07360] [EC:2.7.10.2]
111162046  DNA-binding protein RFX5 [KO:K08061]
111158537  regulatory factor X-associated protein [KO:K08063]
111144209  DNA-binding protein RFXANK [KO:K08062]
111156254  MHC class II transactivator isoform X1 [KO:K08060] [EC:2.7.11.1]
111156453  calcium release-activated calcium channel protein 1 isoform X1 [KO:K16056]
111142747  immunoglobulin lambda-like polypeptide 5 [KO:K06554]
111139538  B-cell antigen receptor complex-associated protein alpha chain [KO:K06506]
111145374  B-cell linker protein isoform X1 [KO:K07371]
111159177  tyrosine-protein kinase BTK isoform X1 [KO:K07370] [EC:2.7.10.2]
111139191  NF-kappa-B essential modulator [KO:K07210]
111141553  tumor necrosis factor receptor superfamily member 5 isoform X1 [KO:K03160]
111139351  CD40 ligand [KO:K03161]
111156546  uracil-DNA glycosylase [KO:K03648] [EC:3.2.2.27]
111142054  single-stranded DNA cytosine deaminase [KO:K10989] [EC:3.5.4.38]
111143804  inducible T-cell costimulator [KO:K06713]
111157707  tumor necrosis factor receptor superfamily member 13C isoform X1 [KO:K05151]
111162308  B-lymphocyte antigen CD19 isoform X1 [KO:K06465]
111139237  tumor necrosis factor receptor superfamily member 13B-like [KO:K05150]
111139257  tumor necrosis factor receptor superfamily member 13B-like [KO:K05150]
Reference
  Authors
Cunningham-Rundles C, Ponda PP.
  Title
Molecular defects in T- and B-cell primary immunodeficiency diseases.
  Journal
Nat Rev Immunol 5:880-92 (2005)
DOI:10.1038/nri1713
Reference
  Authors
Ballow M.
  Title
Primary immunodeficiency disorders: antibody deficiency.
  Journal
J Allergy Clin Immunol 109:581-91 (2002)
DOI:10.1067/mai.2002.122466
Reference
  Authors
Marodi L, Notarangelo LD.
  Title
Immunological and genetic bases of new primary immunodeficiencies.
  Journal
Nat Rev Immunol 7:851-61 (2007)
DOI:10.1038/nri2195
Reference
  Authors
Geha RS, Notarangelo LD, Casanova JL, Chapel H, Conley ME, Fischer A, Hammarstrom L, Nonoyama S, Ochs HD, Puck JM, Roifman C, Seger R, Wedgwood J.
  Title
Primary immunodeficiency diseases: an update from the International Union of Immunological Societies Primary Immunodeficiency Diseases Classification Committee.
  Journal
J Allergy Clin Immunol 120:776-94 (2007)
DOI:10.1016/j.jaci.2007.08.053
Reference
  Authors
Fischer A.
  Title
Human primary immunodeficiency diseases.
  Journal
Immunity 27:835-45 (2007)
DOI:10.1016/j.immuni.2007.11.012
Reference
  Authors
Fischer A.
  Title
Human primary immunodeficiency diseases: a perspective.
  Journal
Nat Immunol 5:23-30 (2004)
DOI:10.1038/ni1023
Reference
  Authors
Buckley RH.
  Title
Primary immunodeficiency diseases due to defects in lymphocytes.
  Journal
N Engl J Med 343:1313-24 (2000)
DOI:10.1056/NEJM200011023431806
Reference
  Authors
Fischer A, Le Deist F, Hacein-Bey-Abina S, Andre-Schmutz I, Basile Gde S, de Villartay JP, Cavazzana-Calvo M.
  Title
Severe combined immunodeficiency. A model disease for molecular immunology and therapy.
  Journal
Immunol Rev 203:98-109 (2005)
DOI:10.1111/j.0105-2896.2005.00223.x
Reference
  Authors
de Villartay JP, Fischer A, Durandy A.
  Title
The mechanisms of immune diversification and their disorders.
  Journal
Nat Rev Immunol 3:962-72 (2003)
DOI:10.1038/nri1247
Related
pathway
elk04640  Hematopoietic cell lineage
elk04660  T cell receptor signaling pathway
elk04662  B cell receptor signaling pathway
KO pathway
ko05340   
LinkDB

DBGET integrated database retrieval system